What is Apnimed, Inc. (APMD)?

Apnimed, Inc. (APMD) is a stock in the Healthcare sector, Biotechnology industry. View full analysis on Stocks360.

What is the current price of APMD?

The current price of APMD is $16.40. Prices are updated in real time on Stocks360.

What is APMD's market capitalization?

APMD's market capitalization is $682,744,776.00, placing it in the small-cap tier.

Apnimed, Inc. (APMD)

Stock analysis · NASDAQ · Healthcare · Biotechnology

$16.40

Market Cap

$682.74M

PE (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

Beta

0.00

Day Range

$16.16 – $17.36

52-wk Range

$16.00 – $35.29

Avg Volume

N/A

Volume

465.68K

Apnimed, Inc. (APMD) is a publicly traded company in the Healthcare sector. Latest price: $16.40. Market cap $682.74M. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2026-07-29 · $16.00 2026-10-30 · $16.40 (+2.50%)

Earnings

Most Recent

Sep 8, 2026

EPS $3.92 vs est. $-0.49

Beat by $4.41

Next Earnings

Dec 8, 2026

EPS estimate $-0.64

Proprietary Signals

Signal snapshot temporarily unavailable.

About Apnimed, Inc.

Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. Its products include AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.

Peers

INSP

Inspire Medical Systems, Inc.